At 4.3% CAGR, the Middle East & Africa dPCR and qPCR Market is Projected to be Worth US$ 504.97 Million by 2030, Says Business Market Insights
According to Business Market Insights research, the Middle East & Africa dPCR and qPCR market was valued at US$ 359.30 million in 2022 and is expected to reach US$ 504.97 million by 2030, registering a CAGR of 4.3% from 2022 to 2030. Growing adoption of PCR methods in emerging countries and development of droplet digital PCR are among the critical factors attributed to the Middle East & Africa dPCR and qPCR market expansion.
In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the Middle East & Africa dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.
On the contrary, high costs of PCR systems hampers the growth of Middle East & Africa dPCR and qPCR market.
Based on treatment, the Middle East & Africa dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 69.7% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 250.52 million. It is projected to garner US$ 365.48 million by 2030 to expand at 4.8% CAGR during 2022-2030.
By product, the Middle East & Africa dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 64.5% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 231.58 million. It is projected to garner US$ 339.38 million by 2030 to expand at 4.9% CAGR during 2022-2030.
By application, the Middle East & Africa dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 56.4% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 202.67 million. It is projected to garner US$ 310.23 million by 2030 to expand at 5.5% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.
By end user, the Middle East & Africa dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 56.4% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 202.67 million. It is projected to garner US$ 310.23 million by 2030 to expand at 5.5% CAGR during 2022-2030.
Based on country, the Middle East & Africa dPCR and qPCR market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 35.9% share of Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 128.82 million. It is projected to garner US$ 191.67 million by 2030 to expand at 5.1% CAGR during 2022-2030.
Key players operating in the Middle East & Africa dPCR and qPCR market are Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.
Contact UsPhone: +16467917070Email Id: sales@businessmarketinsights.com
